MedTrace Logo

Strategic Targeting for Optimal Prevention of Cancer

NCT03897374 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120000

Last updated 2026-03-19

No results posted yet for this study

Summary

The primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition.

Conditions

  • Early Detection of Cancer

Interventions

DIAGNOSTIC_TEST

Genetic Testing

Buccal swab

Sponsors & Collaborators

  • MDGlobal

    collaborator UNKNOWN

  • ClinLogic LLC

    lead INDUSTRY

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-26
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03897374 on ClinicalTrials.gov